This 2020 EMCDDA update on drug-related infectious diseases aims to provide a comprehensive overview of the current situation with regard to the epidemiological picture of drug-related infectious diseases in Europe up to January 2020, while highlighting some of the current innovative responses to the problem.

Table of contents
• At a glance
• Introduction
• European overview of HIV trends and prevalence among people who inject drugs
• HIV continuum of care among people who inject drugs: European countries lag behind treatment and viral suppression targets
• European overview of viral hepatitis prevalence among people who inject drugs
• Viral hepatitis: the EMCDDA elimination barometer supports national monitoring
• Local outbreaks of infectious diseases among people who inject drugs
• Promoting evidence-based interventions
• References